These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15194849)

  • 1. Possible association of Guillain-Barré syndrome and hepatitis A vaccination.
    Blumenthal D; Prais D; Bron-Harlev E; Amir J
    Pediatr Infect Dis J; 2004 Jun; 23(6):586-8. PubMed ID: 15194849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guillain-Barré syndrome and anti-hepatitis A vaccination].
    Roux X; Gramond C; De Greslan T; Sallansonnet-Froment M; Aoun O; Ouologuem M; Taillia H; Renard JL
    Med Mal Infect; 2010 Aug; 40(8):490-2. PubMed ID: 19945808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
    Mehndiratta MM; Chowdhury D; Goel V
    J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
    [No Abstract]   [Full Text] [Related]  

  • 4. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome.
    Leikin JB; Randall DP; Shah DN; Mullings KR; Alleva JT; Hudgins TH
    Dis Mon; 2010 May; 56(5):255-98. PubMed ID: 20493301
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of acute hepatitis a complicated by Guillain-Barré syndrome].
    Bae YJ; Kim KM; Kim KK; Rho JH; Lee HK; Lee YS; Suh DJ
    Korean J Hepatol; 2007 Jun; 13(2):228-33. PubMed ID: 17585196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature.
    Abbi KK; Rizvi SM; Sivik J; Thyagarajan S; Loughran T; Drabick JJ
    Leuk Res; 2010 Jul; 34(7):e154-6. PubMed ID: 20362332
    [No Abstract]   [Full Text] [Related]  

  • 8. Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine.
    Maramattom BV; Krishnan P; Paul R; Padmanabhan S; Cherukudal Vishnu Nampoothiri S; Syed AA; Mangat HS
    Ann Neurol; 2021 Aug; 90(2):312-314. PubMed ID: 34114256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against influenza and Guillain-Barre syndrome: are there any relations?].
    Wiercińska-Drapało A; Grzeszczuk A; Wasilewski K; Prokopowicz D
    Pol Merkur Lekarski; 2000 May; 8(47):360-1. PubMed ID: 10944963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efalizumab-associated Guillain-Barre syndrome.
    Victor F; Menon K; Latkowski JA; Fernandez-Obregon A; Strober BE
    Arch Dermatol; 2008 Oct; 144(10):1396-7. PubMed ID: 18936412
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome.
    Seneviratne U
    Postgrad Med J; 2000 Dec; 76(902):774-82. PubMed ID: 11085768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pregnant woman with hepatitis A and Guillain-Barré.
    Breuer GS; Morali G; Finkelstein Y; Halevy J
    J Clin Gastroenterol; 2001 Feb; 32(2):179-80. PubMed ID: 11205660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic anaemia associated with high dose intravenous immunoglobulin therapy in a child with Guillain-Barré syndrome.
    Trifa M; Simon L; Hamza J; Bavoux F; des Roziers NB
    Arch Dis Child; 2003 Sep; 88(9):836-7. PubMed ID: 12937119
    [No Abstract]   [Full Text] [Related]  

  • 16. Disorder resembling Guillain-Barré syndrome on initiation of statin therapy.
    Rajabally YA; Varakantam V; Abbott RJ
    Muscle Nerve; 2004 Nov; 30(5):663-6. PubMed ID: 15389662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barre Syndrome and COVID-19: A case report.
    Bueso T; Montalvan V; Lee J; Gomez J; Ball S; Shoustari A; Julayanont P; Jumper C
    Clin Neurol Neurosurg; 2021 Jan; 200():106413. PubMed ID: 33338825
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding Guillain-Barré syndrome.
    Estridge R; Iskander M
    JAAPA; 2015 Jul; 28(7):19-22. PubMed ID: 26075345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous immunoglobulin in children with Guillain-Barré syndrome].
    Bruck I; Antoniuk SA; Cat R; Spessatto A; Halick SM; Bruyn LR; Rodrigues M; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1081-91. PubMed ID: 11105076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a second cycle of immunoglobulin justified in axonal forms of Guillain-Barré syndrome?
    Godoy DA; Rabinstein A
    Arq Neuropsiquiatr; 2015 Oct; 73(10):848-51. PubMed ID: 26465402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.